Martin BR - Search Results

1

Pharmacological evaluation of iodo and nitro analogs of delta 8-THC and delta 9-THC.

Martin BR, Compton DR, Semus SF, Lin S, Marciniak G, Grzybowska J, Charalambous A, Makriyannis A. Martin BR, et al. Pharmacol Biochem Behav. 1993 Oct;46(2):295-301. doi: 10.1016/0091-3057(93)90356-x. Pharmacol Biochem Behav. 1993. PMID: 8265683

2

Pharmacological and behavioral evaluation of alkylated anandamide analogs.

Adams IB, Ryan W, Singer M, Razdan RK, Compton DR, Martin BR. Adams IB, et al. Among authors: martin br. Life Sci. 1995;56(23-24):2041-8. doi: 10.1016/0024-3205(95)00187-b. Life Sci. 1995. PMID: 7776830

3

Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs.

Adams IB, Ryan W, Singer M, Thomas BF, Compton DR, Razdan RK, Martin BR. Adams IB, et al. Among authors: martin br. J Pharmacol Exp Ther. 1995 Jun;273(3):1172-81. J Pharmacol Exp Ther. 1995. PMID: 7791088

4

Pharmacological evaluation of dimethylheptyl analogs of delta 9-THC: reassessment of the putative three-point cannabinoid-receptor interaction.

Martin BR, Compton DR, Prescott WR, Barrett RL, Razdan RK. Martin BR, et al. Drug Alcohol Depend. 1995 Mar;37(3):231-40. doi: 10.1016/0376-8716(94)01081-u. Drug Alcohol Depend. 1995. PMID: 7796717

5

Development of cross-tolerance between delta 9-tetrahydrocannabinol, CP 55,940 and WIN 55,212.

Fan F, Compton DR, Ward S, Melvin L, Martin BR. Fan F, et al. Among authors: martin br. J Pharmacol Exp Ther. 1994 Dec;271(3):1383-90. J Pharmacol Exp Ther. 1994. PMID: 7996450

6

The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR. Smith PB, et al. Among authors: martin br. J Pharmacol Exp Ther. 1994 Jul;270(1):219-27. J Pharmacol Exp Ther. 1994. PMID: 8035318

7

Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities.

Compton DR, Rice KC, De Costa BR, Razdan RK, Melvin LS, Johnson MR, Martin BR. Compton DR, et al. Among authors: martin br. J Pharmacol Exp Ther. 1993 Apr;265(1):218-26. J Pharmacol Exp Ther. 1993. PMID: 8474008

8

In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity.

Compton DR, Aceto MD, Lowe J, Martin BR. Compton DR, et al. Among authors: martin br. J Pharmacol Exp Ther. 1996 May;277(2):586-94. J Pharmacol Exp Ther. 1996. PMID: 8627535

9

Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

Showalter VM, Compton DR, Martin BR, Abood ME. Showalter VM, et al. Among authors: martin br. J Pharmacol Exp Ther. 1996 Sep;278(3):989-99. J Pharmacol Exp Ther. 1996. PMID: 8819477

10

Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.

Wiley JL, Compton DR, Gordon PM, Siegel C, Singer M, Dutta A, Lichtman AH, Balster RL, Razdan RK, Martin BR. Wiley JL, et al. Among authors: martin br. Neuropharmacology. 1996;35(12):1793-804. doi: 10.1016/s0028-3908(96)00120-7. Neuropharmacology. 1996. PMID: 9076759

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

635 results

Search Page

Filters